This track focuses on the latest innovations in molecular diagnostic techniques for hematological disorders. Participants will explore how these advancements enhance disease detection and patient management.

This session will delve into the underlying mechanisms of thrombosis and their clinical implications. Experts will discuss recent findings that inform therapeutic strategies and patient care.

This track will highlight cutting-edge therapeutic approaches in the treatment of hematological conditions. Attendees will learn about novel drugs and treatment protocols that improve patient outcomes.

This session emphasizes the importance of translational research in bridging laboratory findings with clinical practice. Researchers will present studies that translate basic science into effective therapies.

This track will explore the discovery and validation of biomarkers in hematology. Discussions will focus on their potential to guide diagnosis, treatment decisions, and prognostic assessments.

This session will address the principles of patient-centered care in the management of hematological diseases. Experts will share strategies to enhance patient engagement and improve health outcomes.